What is ebola

Overview

Ebola virus disease (EVD), also known as Ebola hemorrhagic fever, is a rare but severe and often fatal illness affecting humans and other primates. The disease is caused by infection with one of the Ebola virus species. The virus was first discovered in 1976 and has since caused sporadic outbreaks, primarily in sub-Saharan Africa. The name "Ebola" comes from the Ebola River in the Democratic Republic of the Congo, near the village where one of the first outbreaks occurred.

Transmission and Spread

The Ebola virus spreads through direct contact with blood or other body fluids of a person who is sick with or has died from Ebola virus disease. Transmission can occur through broken skin or mucous membranes. Healthcare workers and family members are at higher risk of infection if they are not properly protected. Fruit bats are believed to be the natural reservoir of the Ebola virus, and contact with infected bats or bushmeat can transmit the virus to humans. Person-to-person transmission can continue as long as blood and body fluids of infected people contain the virus.

Symptoms and Diagnosis

Symptoms of Ebola typically appear between 2 and 21 days after exposure to the virus, with an average of 8 to 10 days. Initial symptoms include fever, intense weakness, muscle pain, and headache. As the disease progresses, patients may experience rash, impaired kidney and liver function, and in some cases, internal and external bleeding. Diagnosis is made through laboratory testing of blood samples from a patient who has been symptomatic for several days. Testing can detect specific antibodies and viral genetic material in the blood.

Treatment and Survival

There is no specific cure for Ebola virus disease. Treatment focuses on supportive care, including rehydration, maintaining oxygen status and blood pressure, and treating any complications that occur. Early supportive care with rehydration and maintenance of oxygen status and blood pressure, as well as treatment of any complications, improves survival rates. Several vaccines have been developed and are being used to prevent outbreaks. The case fatality rate has varied from 25% to 90% depending on virus species and type of outbreak and quality of medical care.

Prevention and Public Health Response

Prevention of Ebola includes avoiding contact with infected individuals and animals, especially fruit bats and non-human primates. Healthcare workers should use appropriate protective equipment and infection control measures. Vaccines are now available and have proven effective in preventing Ebola virus disease. Public health surveillance, rapid identification and isolation of cases, and contact tracing are essential for controlling outbreaks and preventing spread in communities.